How does ABBV's earnings trend compare to peers?

Abbvie's (ABBV) earnings trend is currently negative, with a net loss of $23 million and a diluted EPS of -$0.02 for the latest report period ending on December 31, 2024. This indicates that ABBV has struggled to generate profits in the recent past. |code|Ticker|Name|Date|Total Revenue|Net Income|market_code| |---|---|---|---|---|---|---| |ABBV|ABBV.N|Abbvie|2024 Q1|1.231E10|1.372E9|169| |ABBV|ABBV.N|Abbvie|2024 Q2|1.4462E10|1.373E9|169| |ABBV|ABBV.N|Abbvie|2024 Q3|1.446E10|1.564E9|169| |ABBV|ABBV.N|Abbvie|2024 Q4|1.5102E10|-2.3E7|169| |code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code| |---|---|---|---|---|---|---| |ABBV|ABBV.N|Abbvie|2024 Q1|492.3076923076923|0.77|169| |ABBV|ABBV.N|Abbvie|2024 Q2|-32.45614035087719|0.77|169| |ABBV|ABBV.N|Abbvie|2024 Q3|-12|0.88|169| |ABBV|ABBV.N|Abbvie|2024 Q4|-104.34782608695652|-0.02|169| However, it's important to note that ABBV's revenue for the same period was $15.1 billion, which suggests that the company's top line remains strong despite the net loss. This could be due to factors such as high research and development costs, acquisitions, or other expenses that have impacted profitability. Comparing ABBV's earnings to its peers would require additional information about the peer companies' financial performance. Without this information, it's not possible to provide a comprehensive comparison. However, based on the available data, ABBV's net loss and negative diluted EPS indicate that the company faces significant challenges in generating profits in the near term.